TGF-β and RAS jointly unmask primed enhancers to drive metastasis
Cell · 2024-10 · 187 (22) · 6182-6199.e29
DOI: 10.1016/j.cell.2024.08.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2024-10. Verfasst von Jun Ho Lee und 17 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Hauptthemen laut MEDLINE: Transforming Growth Factor beta, Epithelial-Mesenchymal Transition, Lung Neoplasms, Neoplasm Metastasis. Die Arbeit wurde bisher 87-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Fiona and Stanley Druckenmiller Center for Lung Cancer Research, Institució Catalana de Recerca i Estudis Avançats.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
- Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
- Institute for Research in Biomedicine, The Barcelona Institute of Science and Technology, Barcelona 08028, Spain.
- Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
- Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Tri-Institutional Graduate Program in Computational Biology and Medicine, Weill Corn…
- Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Förderung
- NCI NIH HHS
- Fiona and Stanley Druckenmiller Center for Lung Cancer Research
- Institució Catalana de Recerca i Estudis Avançats
- Agilent Technologies
- European Regional Development Fund
- Howard Hughes Medical Institute
- Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center
- National Institutes of Health
Zitieren
APA
Lee, J. H., Sánchez-Rivera, F. J., He, L., Basnet, H., Chen, F. X., Spina, E., Li, L., Torner, C., Chan, J. E., Yarlagadda, D. V. K., Park, J. S., Sussman, C., Rudin, C. M., Lowe, S. W., Tammela, T., Macias, M. J., Koche, R. P., & Massagué, J. (2024). TGF-β and RAS jointly unmask primed enhancers to drive metastasis. Cell, 187(22), 6182-6199.e29. https://doi.org/10.1016/j.cell.2024.08.014
Vancouver
Lee JH, Sánchez-Rivera FJ, He L, Basnet H, Chen FX, Spina E, et al. TGF-β and RAS jointly unmask primed enhancers to drive metastasis. Cell. 2024;187(22):6182-6199.e29. doi:10.1016/j.cell.2024.08.014
BibTeX
@article{Lee2024,
author = {Lee, Jun Ho and Sánchez-Rivera, Francisco J and He, Lan and Basnet, Harihar and Chen, Fei Xavier and Spina, Elena and Li, Liangji and Torner, Carles and Chan, Jason E and Yarlagadda, Dig Vijay Kumar and Park, Jin Suk and Sussman, Carleigh and Rudin, Charles M and Lowe, Scott W and Tammela, Tuomas and Macias, Maria J and Koche, Richard P and Massagué, Joan},
title = {TGF-β and RAS jointly unmask primed enhancers to drive metastasis},
journal = {Cell},
year = {2024},
volume = {187},
number = {22},
pages = {6182--6199.e29},
doi = {10.1016/j.cell.2024.08.014}
}
EUVIMED